{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:13Z","timestamp":1759403473172,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.03.057","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T15:58:33Z","timestamp":1554566313000},"page":"2580-2585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-8964","authenticated-orcid":false,"given":"Sara","family":"Schartau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte","family":"Heering Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"L\u00fctzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte","family":"Rytter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e5re","family":"M\u00f8lbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"33(36)","key":"10.1016\/j.vaccine.2019.03.057_b0005","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"26","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.03.057_b0010","unstructured":"Danish Medicines Agency. Interactive Adverse Drug Reaction (ADR) Overview. [Last accessed 10 December 2018] Available at <https:\/\/laegemiddelstyrelsen.dk\/en\/sideeffects\/side-effects-from-medicines\/interactive-adverse-drug-reaction-overviews\/>."},{"issue":"4","key":"10.1016\/j.vaccine.2019.03.057_b0015","first-page":"A5064","article-title":"Suspected side effects to the quadrivalent human papilloma vaccine","volume":"62","author":"Brinth","year":"2015","journal-title":"Dan Med J."},{"issue":"1","key":"10.1016\/j.vaccine.2019.03.057_b0020","doi-asserted-by":"crossref","first-page":"00003","DOI":"10.15406\/ijvv.2015.01.00003","article-title":"Is chronic fatigue syndrome\/myalgic encephalomyelitis a relevant diagnosis in patients with suspected side effects to human papilloma virus vaccine?","volume":"1","author":"Brinth","year":"2015","journal-title":"Int J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2019.03.057_b0025","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","article-title":"Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus","volume":"33","author":"Brinth","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.03.057_b0030","doi-asserted-by":"crossref","first-page":"e0162520","DOI":"10.1371\/journal.pone.0162520","article-title":"Pre-vaccination care-seeking in females reporting severe adverse reactions to HPV vaccine. a registry based case-control study","volume":"11","author":"M\u00f8lbak","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2019.03.057_b0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/CLEP.S135318","article-title":"Psychiatric conditions and general practitioner attendance prior to HPV vaccination and the risk of referral to a specialized hospital setting because of suspected adverse events following HPV vaccination: a register-based, matched case-control study","volume":"9","author":"L\u00fctzen","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2019.03.057_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/cky088","article-title":"Socioeconomic predictors of referral to a diagnostic centre on suspected adverse events following HPV vaccination","author":"Weye","year":"2018","journal-title":"Eur J Public Health."},{"key":"10.1016\/j.vaccine.2019.03.057_b0045","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1186\/s12889-018-6268-x","article-title":"Decline in HPV-vaccination uptake in Denmark - the association between HPV-related media coverage and HPV-vaccination","volume":"18","author":"Suppli","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.03.057_b0050","doi-asserted-by":"crossref","unstructured":"P.R. Hansen, and M. Schmidtblaicher. A Dynamic Model of Vaccine Compliance: How Fake News Undermined the Danish HPV Vaccine Program. 2018. Working paper available at [last accessed 10 December 2018] <http:\/\/econ.msu.edu\/seminars\/docs\/Hesitancy.pdf>.","DOI":"10.1080\/07350015.2019.1623045"},{"key":"10.1016\/j.vaccine.2019.03.057_b0055","unstructured":"Sundhedsstyrelsen. \u00c9n Indgang. (Document in Danish, January 2016, available at [last accessed 10 December 2018] <https:\/\/www.sst.dk\/da\/nyheder\/2016\/~\/media\/DC4FA320CCFE44B58911B6E1C9AE3B6D.ashx>."},{"key":"10.1016\/j.vaccine.2019.03.057_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/qshc.2004.011155","article-title":"Making psychological theory useful for implementing evidence based practice: a consensus approach","volume":"14","author":"Michie","year":"2005","journal-title":"Qual Saf Health Care."},{"issue":"27","key":"10.1016\/j.vaccine.2019.03.057_b0065","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.vaccine.2009.06.102","article-title":"Implementation of the Australian HPV vaccination program for adult women: qualitative key informant interviews","volume":"4","author":"Leask","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.03.057_b0070","first-page":"139","article-title":"Experiences of using the theoretical domains framework across diverse clinical environments: a qualitative study","volume":"8","author":"Phillips","year":"2015","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.vaccine.2019.03.057_b0075","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/00002018-200730110-00006","article-title":"Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region","volume":"30","author":"Irujo","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.vaccine.2019.03.057_b0080","series-title":"Research Methods in Public Health","first-page":"91","article-title":"Fieldwork and Participant Observation","author":"Tj\u00f8rnh\u00f8j-Thomsen","year":"2008"},{"key":"10.1016\/j.vaccine.2019.03.057_b0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1472-6963-13-313","article-title":"Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study","volume":"13","author":"Parrella","year":"2013","journal-title":"BMC health Services Res"},{"issue":"1551\u20136","key":"10.1016\/j.vaccine.2019.03.057_b0090","first-page":"9","article-title":"Reporting vaccine-associated adverse events","volume":"43","author":"Duclos","year":"1997","journal-title":"Canadian Family Physician Medecin de Famille Canadien"},{"key":"10.1016\/j.vaccine.2019.03.057_b0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pds.2245","article-title":"Assessing vaccine safety communication with healthcare providers in a large urban county","volume":"21","author":"Meranus","year":"2012","journal-title":"Pharmacoepidemiology Drug Safety"},{"key":"10.1016\/j.vaccine.2019.03.057_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13012-015-0302-5","article-title":"Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach","volume":"10","author":"Mirbaha","year":"2015","journal-title":"Implement Sci"},{"key":"10.1016\/j.vaccine.2019.03.057_b0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5694\/j.1326-5377.2004.tb06158.x","article-title":"Attitudes of doctors and nurses towards incident reporting: a qualitative analysis","volume":"181","author":"Kingston","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2019.03.057_b0110","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.socscimed.2004.08.055","article-title":"Beyond blame: cultural barriers to medical incident reporting","volume":"60","author":"Waring","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2019.03.057_b0115","article-title":"Sample size in qualitative interview studies: guided by information power","author":"Malterud","year":"2015","journal-title":"Qual Health Res"},{"key":"10.1016\/j.vaccine.2019.03.057_b0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40264-016-0456-3","article-title":"Current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in vigibase((R))","volume":"40","author":"Chandler","year":"2017","journal-title":"Drug Saf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:32Z","timestamp":1759401092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19303913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19303913"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}